Xiamen Changrong Investment Management

Xiamen Changrong Investment Management is a venture capital firm specializing in early-stage investments across various sectors. The firm focuses on biotechnology, information technology, health care, medical, pharmaceutical, professional services, consulting, service industry, and clinical trials. It primarily invests in China, the United States, and Malaysia, with typical investment sizes ranging from $10 million to $50 million.

The firm's investment strategy emphasizes sectors such as biotechnology, information technology, health care, medical, pharmaceutical, professional services, consulting, service industry, and clinical trials. Xiamen Changrong Investment Management has a history of leading investments in companies like Anji Pharmaceuticals, indicating its active role in supporting innovative ventures.

With a portfolio that includes companies in biotechnology, information technology, health care, medical, pharmaceutical, professional services, consulting, service industry, and clinical trials, Xiamen Changrong Investment Management demonstrates a diversified approach to early-stage venture capital. The firm's investments span across China, the United States, and Malaysia, reflecting its international reach and commitment to fostering growth in various industries.